OrbiMed Capital GP V LLC's Net Worth

$1.23 Billion

Who is OrbiMed Capital GP V LLC?

OrbiMed Capital GP V LLC has an estimated net worth of $1.23 Billion. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., RHYTHM PHARMACEUTICALS, INC., PMV Pharmaceuticals, Inc., SI-BONE, Inc., Intellia Therapeutics, Inc., Inspire Medical Systems, Inc., Aerpio Pharmaceuticals, Inc., Tricida, Inc., Adaptimmune Therapeutics PLC, ARMO BioSciences, Inc., Loxo Oncology, Inc., Nabriva Therapeutics AG, Dimension Therapeutics, Inc., Aeglea BioTherapeutics, Inc., Compass Therapeutics, Inc., and Corvus Pharmaceuticals, Inc..

SEC CIK

OrbiMed Capital GP V LLC's CIK is 0001615374

Past Insider Trading and Trends

2016 was OrbiMed Capital GP V LLC's most active year for acquiring shares with 20 total transactions. OrbiMed Capital GP V LLC's most active month to acquire stocks was the month of April. 2018 was OrbiMed Capital GP V LLC's most active year for disposing of shares, totalling 29 transactions. OrbiMed Capital GP V LLC's most active month to dispose stocks was the month of October. 2021 saw OrbiMed Capital GP V LLC paying a total of $37,066,528.50 for 8,714,825 shares, this is the most they've acquired in one year. In 2018 OrbiMed Capital GP V LLC cashed out on 65,686,567 shares for a total of $248,478,616.31, their largest year based on trade value.